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Basque Foundation for Science, Bilbao, SpainABSTRACT We present to our knowledge the first structural characterization of the proliferating-cell-nuclear-antigen-associ-
ated factor p15PAF, showing that it is monomeric and intrinsically disordered in solution but has nonrandom conformational pref-
erences at sites of protein-protein interactions. p15PAF is a 12 kDa nuclear protein that acts as a regulator of DNA repair during
DNA replication. The p15PAF gene is overexpressed in several types of human cancer. The nearly complete NMR backbone
assignment of p15PAF allowed us to measure 86 N-HN residual dipolar couplings. Our residual dipolar coupling analysis reveals
nonrandom conformational preferences in distinct regions, including the proliferating-cell-nuclear-antigen-interacting protein
motif (PIP-box) and the KEN-box (recognized by the ubiquitin ligase that targets p15PAF for degradation). In accordance with
these findings, analysis of the 15N R2 relaxation rates shows a relatively reduced mobility for the residues in these regions.
The agreement between the experimental small angle x-ray scattering curve of p15PAF and that computed from a statistical
coil ensemble corrected for the presence of local secondary structural elements further validates our structural model for
p15PAF. The coincidence of these transiently structured regions with protein-protein interaction and posttranslational modifica-
tion sites suggests a possible role for these structures as molecular recognition elements for p15PAF.INTRODUCTIONp15PAF is a 111-residue-long nuclear protein initially identi-
fied as a proliferating-cell-nuclear-antigen (PCNA)-binding
protein in a yeast-two-hybrid screen (1). It binds to PCNA
through its conserved PCNA-interacting protein motif
(PIP-box). p15PAF is a direct transcriptional target of the
activating transcription factor 3, as well as the retinoblas-
toma/E2F pathway (2,3). It is targeted for degradation by
the ubiquitin ligase anaphase-promoting complex/cyclo-
some (APC/C) and its coactivator Cdh1 through the
conserved KEN-box motif at residues 78–80 (4). Indepen-
dent of its APC destruction box, regulatory monoubiquity-
lation at residues K15 and K24 selectively occurs on
PCNA-bound p15PAF during the S phase (5). After ultra-
violet (UV) stress, the interaction of monoubiquitylated
p15PAF with PCNA is disrupted, inducing recruitment of
the translesion synthesis (TLS) polymerase h to PCNA at
stalled replisomes and thus facilitating the bypass of replica-
tion-fork blocking lesions (5). Immunoprecipitation anal-
ysis and a mammalian two-hybrid assay indicate that
p15PAF binds the transactivation region of p53 and strongly
inhibits its transcriptional activity (6). p15PAF is overex-
pressed in multiple types of human cancer and is associated
with poor prognosis (6–8). The structure of p15PAF is un-Submitted September 5, 2013, and accepted for publication December 27,
2013.
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0006-3495/14/02/0865/10 $2.00known, but the amino acid sequence suggests that it is intrin-
sically disordered.
Many proteins lack secondary and/or tertiary structure
under physiological conditions, and these are referred to
as intrinsically disordered proteins (IDPs) (9,10). It is now
widely recognized that IDPs play diverse biological roles
in all kingdoms of life (11). The majority of transcription
factors (12) and proteins involved in signal transduction
(13) in eukaryotes are predicted to be disordered or to
contain long disordered segments. In addition, 79% of
human-cancer-associated proteins have been classified as
IDPs, compared to 47% of all eukaryotic proteins in the
SWISS-PROT database (13). This observation underlines
the importance of intrinsic disorder in the function of pro-
teins that regulate processes often altered in cancer, such
as cell proliferation, DNA repair, and apoptosis.
Structural analysis of IDPs is challenging, because their
polypeptide backbone exhibits a high degree of flexibility
due to rapid interconversion among multiple conformers.
Because of this flexibility, NMR is the main method of
choice for structural and functional studies of unfolded or
partially folded proteins (14). Several NMR observables
have been used to characterize IDPs (15). In particular,
residual dipolar couplings (RDCs) measured in partially
aligned media have been shown to be a sensitive tool for
describing the conformational plasticity observed in IDPs.
RDCs report on the specific dihedral angle space sampled
at the residue level (16), and can be used to quantitatively
estimate the population of secondary-structure elements orhttp://dx.doi.org/10.1016/j.bpj.2013.12.046
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tering (SAXS) has the capacity to report on the three-dimen-
sional space sampled by disordered states and therefore
complements the local information provided by NMR
(18,19). Integration of these experimental data into compu-
tational tools helps to elucidate the structure-function rela-
tionships for this important yet elusive class of proteins (20).
Here, we present to our knowledge the first structural
characterization of human p15PAF. Although circular dichro-
ism (CD) data and NMR chemical shifts are consistent with
a largely disordered protein, backbone 15N NMR relaxation
and RDC measurements reveal the presence of transient
nonrandom structural elements. Based on RDC data,
sparsely populated helical structures localize in a central
region of p15PAF that encompasses the PIP-box, whereas
extended structures are present in regions at the C- and
N-termini. The latter region includes residues K15 and
K24, the sites for ubiquitylation that triggers the protea-
some-dependent removal of p15PAF from the PCNA upon
DNA-replication blockage. Our work identifies partially
structured regions as potential molecular recognition ele-
ments for p15PAF and paves the way for further structural
studies on the functional interactions of p15PAF with other
proteins.MATERIALS AND METHODS
Protein expression and purification
The DNA encoding human p15PAF with codon usage optimized for bacterial
expression cloned into a pET11d vector was purchased from Entelechon.
One liter of Luria broth or M9 minimal medium with the appropriate iso-
topic enrichment (1 g/L 99% 15NH4Cl or 2 g/L 97%
2H7, 99%
13C6-glucose
or 2 g/L 1H7, or 99%
13C6-glucose or 2 g/L natural-abundance glucose, in
99.9% D2O or in H2O) containing 100 mg/mL ampicillin was inoculated
with a clone of Escherichia coli BL21(DE3) cells transformed with the
p15PAF-pET11d construct. Cells were grown at 37C to an OD600 of 0.6,
and protein expression was induced with 1 mM isopropyl b-D-1-thiogalac-
topyranoside for 3 h at 37C. Cells were harvested and resuspended in lysis
buffer (20 mM Tris, pH 8.0, 1 mM dithiothreitol (DTT), and 1 mM EDTA
plus one tablet of the protease inhibitor cocktail cOmplete (Roche, Basel,
Switzerland) and sonicated on ice. Cells were pelleted by centrifugation
at 25,000 rpm for 1 h at 4C, and the supernatant was loaded on a Hiload
26/10 Q Sepharose column (GE Healthcare, Wauwatosa, WI) with a col-
umn volume (CV) of 53 mL. The column was washed with 20 mM Tris,
pH 8.0, 1 mMDTT, and 1 mM EDTA (buffer A), and the protein was eluted
with a two-step gradient using buffer A supplemented with NaCl up to 2 M
total concentration (from 0% to 20% in 0.3 CVand from 20% to100% in 1
CV). Fractions containing the protein (as seen in SDS-PAGE) were pooled
and prepared for reverse-phase chromatography by adding acetonitrile and
trifluoroacetic acid (TFA) to final concentrations of 10% and 0.1%, respec-
tively. Precipitated material was removed using a 0.22 mm filter and the
clarified solution was then loaded on a Phenomenex Jupiter C18 250 
10 mm column with 10 mm particles and a 300 A˚ pore diameter previously
equilibrated with 10% aqueous acetonitrile and 0.1% TFA. The protein was
eluted with a 10–40% gradient of elution buffer (90% aqueous acetonitrile
and 0.1% TFA) in 5 CVs and freeze-dried. SDS-PAGE analysis showed that
the protein coeluted with a p15PAF fragment that lacked the first 18 N-ter-
minal residues, as identified by mass spectrometry. To remove this contam-
inant, a further step using a high-resolution Mono S HR 5/5 column (1 mLBiophysical Journal 106(4) 865–874CV, GE Healthcare) was applied. After solubilizing the freeze-dried mate-
rial in water and adding the necessary reagents to match the composition of
buffer A, p15PAF was injected into the column and eluted with a 0–30%
NaCl gradient in 50 CVs using the same buffer plus 2 M NaCl. Mass spec-
trometry measurements indicated that the initial methionine was processed
by bacterial enzymes. Protein concentration was determined by UV absor-
bance at 280 nm using the extinction coefficient calculated from the amino
acid composition (8605 M1$cm1). The yield of pure protein was around
4 mg/L of Luria broth medium. The yields from cultures in minimal media
were very variable, with a maximum of 2.5 mg/L. Protein samples were
exchanged into different buffers using PD-10 desalting columns (GE
Healthcare) and concentrated by ultrafiltration using Amicon devices
with a 3 kDa cutoff.SEC-MALLS
Size-exclusion chromatography-multiangle laser-light scattering (SEC-
MALLS) experiments were performed at room temperature using a
Superdex 200 10/300 GL column (GE HealthCare) connected to a
DAWN-HELEOS light scattering detector and an Optilab rEX differential
refractive index detector (Wyatt Technology, Santa Barbara, CA). The
column was equilibrated with running buffer (phosphate-buffered saline
(PBS), pH 7.0, 0.03% NaN3, 0.1 mm filtered) and the SEC-MALLS system
was calibrated with a sample of bovine serum albumin (BSA) at 1 g/L in the
same buffer. A sample of 100 mL of p15PAF protein at 1 g/L was injected at
0.5 mL/min. Data acquisition and analysis employed ASTRA software
(Wyatt). Based on numerous measurements on BSA samples at 1 g/L under
the same or similar conditions, we estimate that the experimental error in
molar mass is ~5%.CD spectroscopy
The spectrum of a 50 mM sample of p15PAF in PBS (10 mM phosphate,
140 mM chloride, 153 mM sodium, and 4.5 mM potassium), pH 7.0, and
0.1 mM DTT was recorded on a Jasco-815 spectropolarimeter using a
quartz cuvette (path length, 0.1 mm). Thermal denaturation was induced
by heating (at a rate of 1C/min) a sample of 7.0 mM p15PAF in the same
buffer in a stoppered cuvette with 2 mm pathlength.NMR spectroscopy
Unless otherwise indicated, NMR experiments were recorded at 25C on a
Bruker (Karlsruhe, Germany) Avance III spectrometer operating at 18.8 T
(800 MHz of 1H Larmor frequency) equipped with a TCI cryoprobe and z
gradients. Spectra were processed with TopSpin NMR (Bruker) and
analyzed using Sparky (21). 1H chemical shifts were referenced directly,
and 13C and 15N chemical shifts indirectly (22), to added 2,2-dimethyl-2-
silapentane-5-sulfonate (DSS, methyl 1H signal at 0.00 ppm). The experi-
ments for spectral assignment were obtained using a 0.9 mM U-[13C,
15N] p15PAF sample in water with 5% (v/v) 2H2O and 2 mM DTT, pH 6.3
adjusted with concentrated HCl and NaOH. 1HN, 15N, 13C0, 13Ca, 13Cb
and 1Ha assignments were obtained from the analysis of two-dimensional
1H-15N heteronuclear single quantum coherence (HSQC) and 1H-13C
HSQC, and three-dimensional HNCO, HN(CA)CO, HNCACB, HN(CO)
CACB, HNCA, HN(CO)CA, HN(CA)HA, HN(COCA)HA, and (H)
C(CCO)NH experiments. A partial automatic assignment of the backbone
and 13Cb resonances was obtained with the program MARS (23) and was
manually completed. Side-chain amide groups were assigned using the
HNCO, HN(CO)CACB, and HN(CO)CA spectra. Several Ha assignments
were obtained or confirmed in the 1H-13C HSQC spectrum. The assignment
has been deposited in the BioMagResBank (BMRB ID 19332).
1H-15N RDCs were measured on a 100 mM U-[2H, 13C,15N]-labeled
p15PAF sample in 200 mM sodium 2-(N-morpholino)ethanesulfonate
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acrylamide gel yielding 3.2 Hz splitting of the 2H2O signal. The gel was
prepared with 6% w/v acrylamide and a molar acrylamide/N,N0-methylene-
bisacrylamide ratio of 83:1. A commercial apparatus (Cortecnet, Paris,
France) was used for stretching the gel and inserting it into an open-ended
5 mm NMR tube (24). To overcome the typical overlap problems in the
two-dimensional 1H-15N HSQC of this IDP, we employed a modified
three-dimensional HNCO transverse relaxation-optimized spectroscopy
(TROSY) experiment to resolve and measure a maximal number of
1H-15N RDCs. In this experiment, TROSY and semi-TROSY (in HN) sub-
spectra were recorded in an interleaved manner and with high resolution
(2.5 Hz, interpolated to 0.4 Hz in processing) in the direct 1H dimension;
1H-15N RDCs were then derived from the separation between correspond-
ing spin-state-selective HNa and HNb signals.
The secondary chemical shift values were calculated taking the differ-
ence between experimentally measured 1Ha, 13C0, 13Ca, 13Cb chemical
shifts and their amino-acid-specific random-coil values. Nearest-neighbor
amino acid sequence corrections were introduced in the calculations of
the p15PAF chemical shift deviations from the reference values as described
in the original reports.
Backbone amide 15N transverse (T2) relaxation measurements were
acquired at 25C on a Bruker Avance III spectrometer operating at
23.4 T (1.0 GHz and 101.4 MHz of 1H and 15N Larmor frequencies, respec-
tively) equipped with a TCI cryoprobe and z-gradients. A sample of 180 mM
[U-15N]-p15PAF in 200 mMMES, pH 6.8, 0.5 mMDTT, and 5% 2H2O with
added protease inhibitors (Roche) was used. The pulse sequence for 1H-de-
tected 15N T2 relaxation measurement (25) recorded a series of two-dimen-
sional 1H-15N correlation maps modulated by different 15N T2 relaxation
delays in a fully interleaved mode. This reduces sources of error from envi-
ronmental fluctuations during acquisition. The 15N T2 relaxation delays
were 16.96, 33.92, 50.88, 84.80, 118.72, 169.60, 220.48, and 254.40 ms.
Each 1H-15N correlation map was acquired with 48 scans and 2.5 s of
recycle delay, 2048 direct complex points, and 64 indirect complex points
with an echo/antiecho acquisition scheme. The acquisition times were
t1max ¼ 33.6 ms and t2 ¼ 78.6 ms for the indirect and direct dimensions,
respectively.RDC analysis
Ensembles of explicit models were generated for p15PAF using Flexible-
Meccano, an algorithm that sequentially builds chains of peptide planes
based on amino-acid-specific conformational propensity and volume exclu-
sion (17). This algorithm has been shown to adequately sample the confor-
mational space for unfolded proteins using randomly selected pairs of
dihedral 4,j angles derived from coil regions in high-resolution structures.
To account for deviations from the random-coil description of p15PAF
conformational sampling, different structure ensembles were computed
including user-defined local conformational propensities in continuous
regions of the protein. Canonical secondary-structure backbone dihedral an-
gles were used except in the KEN-box, where the 4,j angles were taken
from the corresponding region in the crystal structure of the protein Mad3
in the crystal structure of the mitotic checkpoint complex (PDB entry
4AEZ). All ensembles comprised 100,000 conformers. For each conformer
in a particular ensemble, the 1H-15N RDCs were predicted by PALES (26),
and the per-residue averages over all conformers were computed and defined
as the simulated RDC values. The quality of each ensemble was assessed by
comparing the simulated and experimental values through a figure of merit:
c2 ¼ 1
N
X
RDCexp  kRDCsim
2
;
where RDCexp and RDCsim are the experimentally measured and simulated
RDC values, respectively, and N is the number of analyzed RDCs. All back-
calculated RDCsim values were scaled uniformly by a factor k to account for
the uncertainty in the degree of sample alignment.Small-angle x-ray scattering
These measurements were carried out at the European Molecular Biology
Laboratory BioSAXS beamline X33 at the DORIS Storage Ring, DESY
(Hamburg, Germany), using an x-ray wavelength of 1.54 A˚ and a sam-
ple-to-detector distance of 2.7 m (27). p15PAF samples were measured at
25C at concentrations of 4.9, 2.9, 2.0, and 1.0 g/L in PBS, pH 7.0, and
1 mM DTT. The scattering patterns of the buffer solutions were recorded
before and after the measurements of each protein sample. The scattering
profiles measured covered a momentum transfer range of 0.0087 < s <
0.60 A˚1. Inspection of the consecutive 30 s x-ray exposures confirmed
that no radiation damage was present. Final curves at each concentration
were derived after the averaged buffer patterns were subtracted from the
protein sample patterns using standard protocols with PRIMUS (28).
No sign of aggregation was observed in any of the curves. In addition,
no concentration effects were observed in the data sets, indicating the
absence of oligomerization equilibria. Consequently, the curve at the
highest concentration, 4.9 g/L, was used for further analysis. The forward
scattering intensity, I(0), and the radius of gyration, Rg, were evaluated
using Guinier’s approximation (29), assuming that at very small angles
(s < 1.3/Rg), the intensity can be well represented as I(s) ¼ I(0)
exp((sRg)2/3). Molecular weight estimation for p15PAF was performed
using a BSA sample at 3.71 g/L as a reference. The pairwise distance
distribution function, p(r), and the maximum particle dimension, Dmax,
were computed with the program GNOM (30), using a momentum transfer
range of 0.015 < s < 0.40 A˚1.
For the simulation of the SAXS curves from RDC-derived ensemble
models, side chains were added to each of the conformers using SCCOMP
(31) and the scattering intensity of each conformer was calculated using
CRYSOL (32). Then, the individual SAXS curves were averaged to yield
the ensemble scattering curve. Both curves were directly compared
by scaling the theoretical curve using a momentum transfer range of
0.015< s< 0.50 A˚1. Constant subtraction was used. A total of 4000 struc-
tures were used to calculate the average curve, which was sufficient to attain
convergence. The coordinates of this ensemble have been deposited in the
Protein Ensemble Database (pE-DB) (33) with accession code 6AAA.RESULTS
Sequence analysis and disorder prediction
The amino acid composition of p15PAF shows a low content
of structure-promoting residues (5.4% aromatic and 12.6%
aliphatic amino acids ) and a high content of disorder-
promoting ones (30.6% charged amino acids), a feature
typical for IDPs (34). The disorder prediction for p15PAF
was made using the metaPrDOS web server, which inte-
grates the results of eight different methods (35). The two-
state prediction output (unfolded versus folded) is consistent
with p15PAF being largely unstructured, with the exception
of residues 51–70, which encompass the PIP-box motif at
residues 62–69 (Fig. 1). The pattern of the PIP-box sequence
is QXXhXXaa, where h is an aliphatic hydrophobic residue
(most frequently I, L, or M), a is an aromatic hydrophobic
residue (F, W, or Y), and X is any of the 20 proteinogenic
amino acids, and is strictly conserved in p15PAF. An N-ter-
minal region centered at V17 and A18 is predicted to have
reduced disorder tendency, suggesting that it may have
some propensity to form transient nonrandom structures.
This region includes monoubiquitylation sites at residues
K15 and K24. The sequence of p15PAF protein containsBiophysical Journal 106(4) 865–874
FIGURE 1 Amino acid sequence features and backbone dynamics of p15PAF. Sites of ubiquitylation (Ub) or phosphorylation (Ph) are indicated by arrows.
Residues encompassing the conserved D-box, PIP-box, and KEN-box motifs are underlined. The solid line shows the disorder prediction by the metaPrDOS
server (left axis) and dotted lines indicate the protein interaction regions predicted by ANCHOR (using a threshold of 0.5). Bars indicate the backbone amide
15N T2 relaxation times at 25
C and 23.4 T (right axis).
868 De Biasio et al.a cyclin-dependent kinase phosphorylation consensus
sequence (residues 72 and 73) and two targeting signals
for the ubiquitin ligase Cdh1-APC complex: a destruction
box (D-box, with the RXXLXXXXN consensus sequence)
at residues 23–34 (36), and a KEN-box at residues 78–80
(37). Interestingly, prediction of protein binding regions us-
ing the web server ANCHOR (38) identifies three sequence
segments (11–27, 47–73, and 89–102), two of which corre-
spond to regions with reduced disorder tendencies.Cloning, expression, and purification
The polypeptide studied here corresponds to p15PAF isoform
1, the canonical sequence comprising the full-length protein
(Uniprot Q15004) coded by the human KIAA0101 gene. No
additional residues that could perturb the native structural
features of this putative IDP were introduced. Since no
affinity tag was used, high expression levels of the recombi-
nant gene were necessary for efficient protein purification.
Considering that the human cDNA sequence coded seven
of the eight arginine residues with codons that are at low
abundance in E. coli, a synthetic gene with codons opti-
mized for bacterial expression was used. Protein p15PAF
was then purified by three sequential chromatographic
separations. As frequently occurs with recombinant gene
expression in bacteria, the initial methionine was processed
and the purified protein consists predominantly of residues
2–111 of p15PAF, with a small amount (~10%) of the intact
chain.Structural analysis by SEC-MALLS and CD
The protein eluted from the SEC column at a volume that,
according to the calibration with molecular weight stan-
dards, corresponds to an apparent molar mass of 25 kDa.
However, the mass derived from the MALLS data isBiophysical Journal 106(4) 865–87411.5 kDa (Fig. 2 A), demonstrating that p15PAF is mono-
meric. These inconsistent results suggest that p15PAF is
either folded with an elongated shape or is flexible and
disordered (39). In both instances, it would elute at a smaller
volume than a globular protein of the same mass.
The far-UV CD spectrum of p15PAF shows a minimum
at 198 nm and a shoulder at 222 nm, consistent with a pre-
dominantly random-coil protein with little secondary struc-
ture (Fig. 2 B). The thermal denaturation curve of p15PAF
followed by the changes in the CD signal at 222 nm (see
Fig. 2 B, inset) does not show any cooperative folding-
unfolding transition, indicating that p15PAF lacks a defined
tertiary structure.NMR assignment and analysis
The resonances of the p15PAF backbone nuclei and the
aliphatic side-chain carbon resonances were assigned using
conventional triple resonance spectra with amide proton
signal detection. For the two initial N-terminal residues
(V2 and R3), no crosspeaks were observed in the 1H–15N
HSQC spectrum. For the 99 remaining nonproline residues,
all the 1H-15N correlation signals could be unambiguously
assigned (Fig. 3). The p15PAF protein contains nine proline
residues whose preceding peptide bond is in the trans
configuration, as inferred by the differences in the proline
Cb and Cg chemical shifts (40). A few signals with ~5%
the intensity of the major ones are observed in the 1H-15N
HSQC spectrum (data not shown). At least four of these
signals correspond to residues preceded by a proline with
13Cb and 13Cg chemical shifts typical for the cis configura-
tion. Therefore, we interpret them as arising from small
populations of p15PAF molecules with cis isomers at some
of the peptidyl-prolyl peptide bonds.
The lack of dispersion in the backbone amide 1H chemi-
cal shifts as seen in the 1H-15N HSQC spectrum gives
FIGURE 2 p15PAF is monomeric and has little structure in solution. (A)
Size-exclusion chromatogram of p15PAF in PBS, pH 7.0, at room tempera-
ture (dotted line and left axis), and molar mass derived from MALLS (solid
line and right axis). (B) CD spectrum of p15PAF in PBS, pH 7.0, at 25C.
(Inset) Thermal denaturation as measured by changes in the signal at
222 nm.
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p15PAF under native conditions. The average 15N transverse
relaxation time (T2) measured at 25
C and 23.4 T is
~300 ms, similar to the reported values for a disordered
protein from measles virus at the same temperature and
magnetic field strength (41). However, several regions of
p15PAF show relatively short T2 values (Fig. 1), and two
of them correspond to sequences with reduced predicted dis-
order tendency. A shorter-than-average T2 might indicate
restricted local flexibility on a fast timescale (nanoseconds
to picoseconds) or conformational motions on a slow time-
scale (microseconds to milliseconds) that typically engulf
several contiguous residues. However, either interpretation
points to the same result: the rather unrestricted and discon-
nected flexibility characteristic of IDPs is somewhat altered
toward more restricted and connected mobility. There is a
certain correlation between local residue bulkiness and
transverse relaxation rates R2 (the inverse of T2; see
Fig. S1 in the Supporting Material), suggesting that local
restrictions in polypeptide chain dynamics can be explainedin part by steric interactions between side chains and the
backbone, as found for other IDPs (42).
Chemical shift deviations from random-coil values were
computed using four different sets of reference values.
Three sets were experimentally obtained from small disor-
dered peptides (43–45). The fourth is a set of values derived
from the NMR assignments of 14 IDPs under native condi-
tions (46). At the level of sensitivity of chemical shifts, this
analysis did not provide consistent evidence of preferred
conformations in p15PAF, suggesting that its behavior is
close to that of a random coil. The deviations calculated
for the Ha, C0, Ca, and Cb nuclei using one of the peptide-
derived data sets and the IDP-derived data set are shown
in Fig. S2.
1H-15N RDCs of p15PAF measured in a stretched poly-
acrylamide gel aligning medium are mainly negative
(Fig. 4, black circles), as observed in disordered proteins
(16,47). As RDC variations in unfolded proteins are mainly
dictated by the steric hindrance between neighboring resi-
dues, the RDC profile is also sequence-specific, with larger
RDCs observed where bulky amino acids are present (42).
To assess whether any nonrandom structure is present in
p15PAF, we looked for deviations in the RDC experimental
profile from the behavior expected for a random coil with
the p15PAF sequence. For that purpose, we applied the Flex-
ible Meccano approach (48) to build ensembles of p15PAF
models with randomly selected torsion angle pairs drawn
from a database of amino-acid-specific conformations
present in loop regions of high-resolution x-ray structures
(17). The alignment tensor was predicted for each
conformer using PALES (26), and the associated RDCs
were calculated for each 1H-15N vector with respect to
this tensor. RDCs from each site were then averaged over
100,000 conformers to ensure convergence. The values
calculated from this statistical coil ensemble (Fig. 4, blue
line) were then compared to the experimental RDCs. Three
regions are identified in the p15PAF sequence for which there
is a disagreement between the experimental and calculated
RDCs: a central region (residues 54–69), an N-terminal
region (residues 15–24), and a C-terminal region (residues
94–104). Since the random-coil model did not fully repro-
duce the measured RDCs, different structurally biased
ensembles of 100,000 conformers were computed by
systematically forcing distinct secondary-structure popula-
tions within the p15PAF sequence. These ensembles were
quantitatively evaluated by comparison of the predicted
RDCs with the experimental ones. The best agreement
was found by imposing 15% a-helix and 310 helix in resi-
dues 54–60 and 67–69, respectively, and 8% b-strand in
residues 15–24 and 94–104 (Fig. 4, red line). The correla-
tion between calculated and measured RDCs was further
improved by introducing 15% of torsion angles for
canonical inverse g-turn structure in W61, and 5% of
KEN-box torsion angles in p15PAF residues 76–80. These
angles were taken from the KEN-box-containing segmentBiophysical Journal 106(4) 865–874
FIGURE 3 Residue-specific assignment of the
1H-15N HSQC NMR spectrum of p15PAF at
pH 6.3 and 25C. The pairs of signals from the
side-chain amides of asparagine and glutamine res-
idues are arbitrarily labeled ND1/ND2 and NE1/
NE2, respectively, without implying a stereospe-
cific assignment. (Inset) Signal from the W61
indole group.
870 De Biasio et al.(residues18–22) of the mitotic spindle assembly checkpoint
protein Mad3 bound to the APC/C coactivator protein
CdC20 (49). Introduction of these secondary-structure pref-
erences in the indicated regions not only results in a notable
agreement with the measured RDCs in those regions but
also improves the correlation along the entire chain.SAXS analysis
We used SAXS to characterize the conformational space
sampled by p15PAF in solution and to validate the structure
ensemble derived from the RDC data. As shown in Fig. 5,
the SAXS profile of p15PAF and its Kratky representation
are typical for a disordered protein. The SAXS curve shows
no features (Fig. 5 A) and the Kratky plot does not show a
maximum, with a monotonic increase at large momentum
transfer values (Fig. 5 B). Analysis of the smallest angles
by Guinier’s approach using a momentum transfer range
of sRg < 1.3 (where s is the momentum transfer and Rg is
the radius of gyration) indicates the presence of a particle
with Rg ¼ 28.1 5 0.3 A˚ and an estimated molecular mass
of 12.6 kDa. The latter is in excellent agreement with the
calculated molar mass of 11.9 kDa for the p15PAF monomer.Biophysical Journal 106(4) 865–874The Rg of p15
PAF is slightly smaller than expected for a 110-
residue-long random-coil polypeptide (Rg
RC ¼ 29.5 A˚),
suggesting that p15PAF could transiently adopt a less
extended structure (50). The disordered nature of p15PAF
is substantiated by the large value of the maximum particle
dimension (Dmax ¼ 1205 10 A˚). The average of the scat-
tering curves and the Kratky plots calculated for the 4000
conformations that best explain the RDC measurements
are represented by black lines in Fig. 5. The experimental
SAXS data were accurately reproduced by those calculated
for the ensemble of p15PAF models, indicating that this
ensemble is a good representation of the conformational
distribution of p15PAF in solution.DISCUSSION
Our SEC-MALLS, CD, SAXS, and NMR measurements
show that p15PAF is monomeric in solution, with no tertiary
structure and few conformational preferences. Its large
conformational heterogeneity makes a detailed structural
characterization of this IDP challenging, since experi-
mental data are ensemble-averaged (51). Validating the
combined local structural information from RDCs and
FIGURE 4 Local nonrandom structures in the conformational ensemble of p15PAF. Comparison of the experimental RDCs (black circles) with those simu-
lated using a random-coil ensemble without any structural bias (blue line) and those calculated including the conformational preferences described in the text
(red line). The estimated error in the measured RDCs is50.4 Hz (indicated by the error bars). Calculated RDCs are plotted only if the corresponding exper-
imental value was available. Those regions where nonrandom structures were detected are shaded in blue (extended structure), red (helical structure), or green
(inverse g-turn and KEN-box structures). To see this figure in color, go online.
Disorder and Structural Preferences in p15PAF 871global shape information provided by SAXS against
computer-generated conformational ensembles has been a
powerful approach in performing this demanding task
(52). Chemical-shift analysis alone did not consistently
detect nonrandom regions, whereas analysis of the back-
bone amide RDCs precisely indicated specific regions
in p15PAF that significantly deviate from random-coil
structure. We do not fully understand the origin of this
apparent contradiction, but we think that it may be because
1), p15PAF contains very little nonrandom structure; 2), the
quality of the available random-coil chemical-shift refer-
ence data sets limits the detection of these low populations
of nonrandom structures; 3), the reference RDC values
calculated for a sufficiently large random-coil ensemble
allow more sensitive detection of nonrandom structures.
The latter two reasons may be especially relevant in the
case of p15PAF due to an unknown property feature of this
protein.
As anticipated by disorder-tendency predictions, the
central p15PAF region encompassing residues 54–69 shows
the major deviations from a random coil. Within this region,
residues 67EFF69 have detectable 310 helical propensities.
These three residues are C-terminal in the conserved PIP-
box motif of p15PAF that mediates its binding to PCNA.
Our analysis also shows that the RDC deviations of the eight
residues preceding the PIP-box (54CVRPTPKW61) can be
explained by a larger-than-random propensity for a-helical
dihedral angles in residues 54–60 and g-turn angles in
W61. The detection of helical structure in this region may
be surprising at first, given the presence of two prolines.
However, RDCs report on time- and ensemble-averaged
conformations that do not necessarily imply a continuouseight-residue-long helical structure as the major nonrandom
conformation. Prolines generally destabilize a-helical (and
b-strand) structures, but they can nevertheless be accommo-
dated, and may even be preferred as N-capping residues in a
helix (53). Further nonrandom local structure was detected
in the N- and C-terminal regions of p15PAF, and within the
KEN-box motif (residues 78–80).
The functional advantage of IDPs presumably derives
from their conformational versatility, allowing for inter-
actions with different ligands, and for extensive regulation
through posttranslational modifications at many accessible
sites (54). Many IDPs fold upon binding to their partners
(55). This may occur via 1), induced fit, in which the binding
partner induces the disordered protein to adopt the bound-
state conformation; 2), conformational selection, in which
the binding partner selects a binding-efficient conformation
from the ensemble sampled in the free state; or 3), a mixture
of induced fit and conformational selection (56,57).
Several reports in the literature show that p15PAF interacts
with other proteins. Based on results of yeast two-hybrid
and coimmunoprecipitation experiments using wild-type
and mutant p15PAF expressed in mammalian cells, Yu
et al. (1) assert that p15PAF interacts with PCNA through
its PIP-box. Liu and colleagues (6) report, based on their
coimmunoprecipitation and two-hybrid experiments, that
p15PAF interacts with p53, although the interaction sites
are unknown. And based on the increased protein levels in
null-Cdh1 cells, and using KEN-box mutants, Emanuele
et al. (4) report that p15PAF interacts with APC/C-Cdh1
through its KEN-box. However, none of these interactions
has been validated by structural and/or quantitative experi-
mental methods using pure proteins (58).Biophysical Journal 106(4) 865–874
FIGURE 5 SAXS data and analysis of p15PAF in PBS, pH 7.0, at 25C.
(A) Semilogarithmic representation of SAXS intensity versus momentum
transfer (gray circles), and the back-calculated curve derived from the
conformational ensemble that best explains the experimental RDCs (solid
black line). The residuals of the fitting are shown below (dashed line and
gray circles). (B) Kratky plot of the data shown in A.
872 De Biasio et al.In all of the crystal structures of PIP-box peptides or pro-
teins bound to PCNAs reported in the literature, both
conserved aromatic residues of the PIP-box bind to the
same hydrophobic groove on the PCNA surface and are
part of a 310 helical turn (59–64). If the PIP-box residuesBiophysical Journal 106(4) 865–874of p15PAF bind to PCNAs in the same conformation as
seen in homologous structures, a conformational selection
mechanism might contribute to the binding. However, to
confirm and evaluate the extent of this possible contribution
relative to an induced-fit mechanism, it would be necessary
to determine the p15PAF/PCNA complex structure and
describe the different populations and kinetic rates for
both mechanisms (65). The preference for helical structure
in the eight residues preceding the PIP-box may represent
their PCNA-bound conformation, providing further con-
tacts beyond the strict PIP-box. These residues N-terminal
to the PIP-box are not conserved in PCNA interacting pro-
teins. In the crystal structures of peptides bound to PCNAs,
only a few residues preceding the PIP-box sequence are
seen, and these adopt an extended structure. However, in
the structures of both the full-length human flap endonu-
clease 1 protein bound to PCNA (64) and the yeast replica-
tion factor C bound to yeast PCNA (59), some of the
nonconserved residues N-terminal to the PIP-box fold into
a helical structure (but there is no proline in either of these
PCNA-bound sequences). In the KEN-box and the N-termi-
nal region, there are three lysines (K15, K24, and K78)
that are known targets of regulatory ubiquitylation. The
observed preferred conformations in these regions may
play a role in the recognition by the ubiquitylation complex.
In this context, it is interesting to note that monoubiquityla-
tion at K15 and K24 of chromatin-associated p15PAF is tem-
plated through PCNA binding (5), and that ubiquitylation
sites tend not to be located in disordered regions (66). It
is tempting to speculate that binding to PCNAs may stabi-
lize the observed local structure and/or induce additional
structure around K15 and K24 that facilitates the recogni-
tion of p15PAF as a target for ubiquitylation.
The cyclin-dependent kinase inhibitor p21CIP1 is another
IDP that interacts with diverse ligands via distinct regions
and competes with p15PAF for PCNA binding through its
PIP-box (1). However, a detailed conformational analysis
of p21CIP1 has been hampered by the low solubility of this
protein, and only small fragments have been studied (67).
Our work on full-length p15PAF paves the way for further
structural studies on its interactions with physiological
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